NCT06929442 A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences
| NCT ID | NCT06929442 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Massachusetts General Hospital |
| Condition | Psychotic Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 192 participants |
| Start Date | 2025-02-10 |
| Primary Completion | 2028-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 192 participants in total. It began in 2025-02-10 with a primary completion date of 2028-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomized controlled trial testing the efficacy of Resilience Training in college students with elevated transdiagnostic risk for developing a serious mental illness.
Eligibility Criteria
Inclusion criteria: 1. 18-30 years old 2. Enrolled as a first or second year student (i.e., freshman or sophomore) in an undergraduate program at the college or university where the intervention takes place 3. Students who endorse some psychotic experiences (Peter's et al. Delusion Inventory (PDI) score \> 3) Exclusion criteria: 1. Inability to provide informed consent 2. Not proficient in English 3. Current self-reported Diagnostic Statistical Manual 5 (DSM-5) diagnosis with active symptoms (such as active psychotic symptoms, current suicidality, serious active alcohol or substance use, marked deterioration in functioning over the prior month) determined by clinical interview with participant, or self-report of a psychiatric diagnosis that necessitates close monitoring or individual therapy and/or inpatient or partial hospitalization 4. Current enrollment in psychological or behavioral health treatment. 5. Current use of psychotropic medications (other than stimulants) prescribed by a physician. 6. A diagnosis of a serious, chronic mental illness as determined by the Mini-International Neuropsychiatric Interview (MINI)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06929442 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Psychotic Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06929442 currently recruiting?
Yes, NCT06929442 is actively recruiting participants. Contact the research team at dholt@mgh.harvard.edu for enrollment information.
Where is the NCT06929442 trial being conducted?
This trial is being conducted at Charlestown, United States.
Who is sponsoring the NCT06929442 clinical trial?
NCT06929442 is sponsored by Massachusetts General Hospital. The trial plans to enroll 192 participants.